Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000658286 | SCV000340140 | uncertain significance | not provided | 2017-11-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000658286 | SCV000780057 | benign | not provided | 2019-10-21 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28649525) |
Labcorp Genetics |
RCV001079376 | SCV001052148 | likely benign | Bifunctional peroxisomal enzyme deficiency; Perrault syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001835757 | SCV002075424 | likely benign | Bifunctional peroxisomal enzyme deficiency | 2020-01-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004535368 | SCV004735903 | likely benign | HSD17B4-related disorder | 2022-02-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |